{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:19:57Z","timestamp":1790147997341,"version":"4.0.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,23]],"date-time":"2024-11-23T00:00:00Z","timestamp":1732320000000},"content-version":"am","delay-in-days":358,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI133976"],"award-info":[{"award-number":["R01AI133976"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01AI145890"],"award-info":[{"award-number":["R01AI145890"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01HD098713"],"award-info":[{"award-number":["R01HD098713"]}],"id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ajog.2023.07.042","type":"journal-article","created":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T20:52:29Z","timestamp":1690491149000},"page":"647-655","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Addressing a broken drug pipeline for preterm birth: why early preterm birth is an orphan disease"],"prefix":"10.1016","volume":"229","author":[{"given":"Carly","family":"Baxter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Crary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brahm","family":"Coler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Marcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily M.","family":"Huebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Rutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6939-7224","authenticated-orcid":false,"given":"Kristina M.","family":"Adams Waldorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl1","key":"10.1016\/j.ajog.2023.07.042_bib1","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1186\/1742-4755-10-S1-S2","article-title":"Born too soon: the global epidemiology of 15 million preterm births","volume":"10","author":"Blencowe","year":"2013","journal-title":"Reprod Health"},{"key":"10.1016\/j.ajog.2023.07.042_bib2","unstructured":"Kinney M, Howson CP, McDougall L, Lawn JE. Executive summary for born too soon: the global action report on preterm birth. Geneva, Switzerland: March of Dimes, PMNCH, Save the Children, World Health Organization; 2012."},{"key":"10.1016\/j.ajog.2023.07.042_bib3","first-page":"1","article-title":"Births: final data for 2020","volume":"70","author":"Osterman","year":"2021","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2023.07.042_bib4","first-page":"1","article-title":"Births: final data for 2021","volume":"72","author":"Osterman","year":"2023","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2023.07.042_bib5","doi-asserted-by":"crossref","first-page":"F225","DOI":"10.1136\/adc.2009.161117","article-title":"A\u00a0structured review of the recent literature on the economic consequences of preterm birth","volume":"96","author":"Petrou","year":"2011","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"10.1016\/j.ajog.2023.07.042_bib6","first-page":"2912","article-title":"Landscape of preterm birth therapeutics and a path forward","volume":"10","author":"Coler","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.ajog.2023.07.042_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ajog.2020.09.045","article-title":"A\u00a0chronicle of the 17-alpha hydroxyprogesterone caproate story to prevent recurrent preterm birth","volume":"224","author":"Nelson","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib8","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1097\/AOG.0000000000004479","article-title":"Prediction and prevention of spontaneous preterm birth: ACOG Practice Bulletin, Number 234","volume":"138","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ajog.2021.02.032","article-title":"Prescription medications for use in pregnancy-perspective from the US Food and Drug Administration","volume":"225","author":"Wesley","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajog.2021.04.227","article-title":"Drug development research in pregnant and lactating women","volume":"225","author":"Ren","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ajog.2021.02.002","article-title":"Obstetrical, fetal, and lactation pharmacology-a crisis that can no longer be ignored","volume":"225","author":"Caritis","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajog.2021.03.024","article-title":"Women and babies are dying from inertia: a collaborative framework for obstetrical drug development is urgently needed","volume":"225","author":"Roset Bahmanyar","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib13","doi-asserted-by":"crossref","first-page":"124.e1","DOI":"10.1016\/j.ajog.2011.12.003","article-title":"Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and metaanalysis of individual patient data","volume":"206","author":"Romero","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0140-6736(19)32973-3","article-title":"Low-dose aspirin for the prevention of preterm delivery in nulliparous women with a singleton pregnancy (ASPIRIN): a randomised, double-blind, placebo-controlled trial","volume":"395","author":"Hoffman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.07.042_bib15","first-page":"10","article-title":"Orphan products: hope for people with rare diseases","volume":"37","author":"Rados","year":"2003","journal-title":"FDA Consum"},{"key":"10.1016\/j.ajog.2023.07.042_bib16","unstructured":"Orphan Drug ActAE 2111. United States of America: U.S. Government Printing Office, 1983 (vol 96 Stat. 2049)."},{"key":"10.1016\/j.ajog.2023.07.042_bib19","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1126\/science.1251816","article-title":"Preterm labor: one syndrome, many causes","volume":"345","author":"Romero","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ajog.2023.07.042_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.ajog.2019.05.044","article-title":"Placental bed research: I. The placental bed: from spiral arteries remodeling to the great obstetrical syndromes","volume":"221","author":"Brosens","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ajog.2010.08.009","article-title":"The \u201cGreat Obstetrical Syndromes\u201d are associated with disorders of deep placentation","volume":"204","author":"Brosens","year":"2011","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib22","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0002-9378(99)70111-0","article-title":"The preterm prediction study: effect of gestational age and cause of preterm birth on subsequent obstetric outcome. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network","volume":"181","author":"Mercer","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib23","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.ajog.2006.06.033","article-title":"The Alabama preterm birth study: corticosteroids and neonatal outcomes in 23- to 32-week newborns with various markers of intrauterine infection","volume":"195","author":"Goldenberg","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.284.7.843","article-title":"The contribution of mild and moderate preterm birth to infant mortality. Fetal and infant health study group of the Canadian perinatal surveillance system","volume":"284","author":"Kramer","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.07.042_bib25","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/s41372-020-0635-z","article-title":"Estimates of healthcare spending for preterm and low-birthweight infants in a commercially insured population: 2008-2016","volume":"40","author":"Beam","year":"2020","journal-title":"J\u00a0Perinatol"},{"key":"10.1016\/j.ajog.2023.07.042_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.semperi.2021.151390","article-title":"Preterm birth lifetime costs in the United States in 2016: an update","volume":"45","author":"Waitzman","year":"2021","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2023.07.042_bib27","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/pds.1317","article-title":"Effectiveness and safety of ritodrine hydrochloride for the treatment of preterm labour: a systematic review","volume":"15","author":"Yaju","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2023.07.042_bib28","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1056\/NEJMoa035140","article-title":"Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate","volume":"348","author":"Meis","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.07.042_bib29","doi-asserted-by":"crossref","first-page":"364.e1","DOI":"10.1016\/j.ajog.2015.05.009","article-title":"17-hydroxyprogesterone caproate for preterm rupture of the membranes: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"213","author":"Combs","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0039-3400227","article-title":"17-OHPC to prevent recurrent preterm birth in singleton gestations (PROLONG study): a multicenter, international, randomized double-blind trial","volume":"37","author":"Blackwell","year":"2020","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2023.07.042_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ogc.2005.05.001","article-title":"\u03b2-agonist tocolytic therapy","volume":"32","author":"Lam","year":"2005","journal-title":"Obstet Gynecol Clin North Am"},{"key":"10.1016\/j.ajog.2023.07.042_bib32","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1001\/jama.2020.1486","article-title":"Confirmatory trial for drug to prevent preterm birth finds no benefit, so why is it still prescribed?","volume":"323","author":"Rubin","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.07.042_bib33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1067\/mob.2000.95834","article-title":"An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue","volume":"182","author":"Romero","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib34","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.ajog.2013.04.027","article-title":"Progesterone is not the same as 17alpha-hydroxyprogesterone caproate: implications for obstetrical practice","volume":"208","author":"Romero","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265853","article-title":"Is there a maternal blood biomarker that can predict spontaneous preterm birth prior to labour onset? A systematic review","volume":"17","author":"Hornaday","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2023.07.042_bib36","doi-asserted-by":"crossref","first-page":"132.e1","DOI":"10.1016\/j.ajog.2021.10.035","article-title":"In utero exposure to 17alpha-hydroxyprogesterone caproate and risk of cancer in offspring","volume":"226","author":"Murphy","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib37","first-page":"1","article-title":"Infant mortality in the United States, 2019:data from the period linked birth\/infant death file","volume":"70","author":"Ely","year":"2021","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/j.ajog.2023.07.042_bib38","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41572-019-0127-7","article-title":"Bronchopulmonary dysplasia","volume":"5","author":"Th\u00e9baud","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ajog.2023.07.042_bib39","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1056\/NEJMoa067815","article-title":"Fetal Medicine Foundation Second Trimester Screening Group. Progesterone and the risk of preterm birth among women with a short cervix","volume":"357","author":"Fonseca","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.07.042_bib40","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/uog.9017","article-title":"Vaginal progesterone reduces the rate of preterm birth in women with a sonographic short cervix: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"38","author":"Hassan","year":"2011","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib41","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/uog.17397","article-title":"Vaginal progesterone decreases preterm birth and neonatal morbidity and mortality in women with a twin gestation and a short cervix: an updated meta-analysis of individual patient data","volume":"49","author":"Romero","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib42","first-page":"CD014978","article-title":"Tocolytics for delaying preterm birth: a network meta-analysis (0924)","volume":"8","author":"Wilson","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ajog.2023.07.042_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/708023","article-title":"The evidence regarding maintenance tocolysis","volume":"2013","author":"Elliott","year":"2013","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.ajog.2023.07.042_bib44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4274\/tjod.galenos.2023.47715","article-title":"Antenatal azithromycin to prevent preterm birth in pregnant women with vaginal cerclage: a randomized clinical trial","volume":"20","author":"Ahmed","year":"2023","journal-title":"Turk J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib45","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/01.AOG.0000435415.21944.8f","article-title":"Practice bulletins no. 139: premature rupture of membranes","volume":"122","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s12974-020-02032-8","article-title":"An allosteric interleukin-1 receptor modulator mitigates inflammation and photoreceptor toxicity in a model of retinal degeneration","volume":"17","author":"Dabouz","year":"2020","journal-title":"J\u00a0Neuroinflammation"},{"key":"10.1016\/j.ajog.2023.07.042_bib47","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.4049\/jimmunol.1601600","article-title":"Antenatal suppression of IL-1 protects against inflammation-induced fetal injury and improves neonatal and developmental outcomes in mice","volume":"198","author":"Nadeau-Vall\u00e9e","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2023.07.042_bib48","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.4049\/jimmunol.1500758","article-title":"Novel noncompetitive IL-1 receptor-biased ligand prevents infection- and inflammation-induced preterm birth","volume":"195","author":"Nadeau-Vall\u00e9e","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2023.07.042_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0257847","article-title":"Direct administration of the non-competitive interleukin-1 receptor antagonist rytvela transiently reduced intrauterine inflammation in an extremely preterm sheep model of chorioamnionitis","volume":"16","author":"Takahashi","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2023.07.042_bib50","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.4049\/jimmunol.180.10.6977","article-title":"Development of a novel noncompetitive antagonist of IL-1 receptor","volume":"180","author":"Quiniou","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.ajog.2023.07.042_bib51","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1053\/j.semperi.2008.07.001","article-title":"Interleukin-1 and ischemic brain injury in the newborn: development of a small molecule inhibitor of IL-1 receptor","volume":"32","author":"Quiniou","year":"2008","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2023.07.042_bib52","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/ATVBAHA.113.301331","article-title":"Microglia and interleukin-1beta in ischemic retinopathy elicit microvascular degeneration through neuronal semaphorin-3A","volume":"33","author":"Rivera","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ajog.2023.07.042_bib53","doi-asserted-by":"crossref","first-page":"467.e1","DOI":"10.1016\/j.ajog.2022.10.007","article-title":"Pharmacodynamic characterization of rytvela, a novel allosteric anti-inflammatory therapeutic, to prevent preterm birth and improve fetal and neonatal outcomes","volume":"228","author":"Habelrih","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30087-4","article-title":"Antenatal IL-1-dependent inflammation persists postnatally and causes retinal and sub-retinal vasculopathy in progeny","volume":"8","author":"Beaudry-Richard","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajog.2023.07.042_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/107155769700400104","article-title":"Treatment with the interleukin-I receptor antagonist and soluble tumor necrosis factor receptor Fc fusion protein does not prevent endotoxin-induced preterm parturition in mice","volume":"4","author":"Fidel","year":"1997","journal-title":"J\u00a0Soc Gynecol Investig"},{"key":"10.1016\/j.ajog.2023.07.042_bib56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cytogfr.2020.12.004","article-title":"The determinant role of IL-6 in the establishment of inflammation leading to spontaneous preterm birth","volume":"59","author":"Prairie","year":"2021","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ajog.2023.07.042_bib57","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1111\/bcp.13622","article-title":"Pharmacokinetics, safety and tolerability of OBE022, a selective prostaglandin F2alpha receptor antagonist tocolytic: a first-in-human trial in healthy postmenopausal women","volume":"84","author":"Pohl","year":"2018","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2023.07.042_bib58","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/bcp.13925","article-title":"Coadministration of the prostaglandin F2alpha receptor antagonist preterm labour drug candidate OBE022 with magnesium sulfate, atosiban, nifedipine and betamethasone","volume":"85","author":"Pohl","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2023.07.042_bib59","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/cpdd.447","article-title":"Confirmation of the cardiac safety of PGF2alpha receptor antagonist OBE022 in a first-in-human study in healthy subjects, using intensive ECG assessments","volume":"7","author":"T\u00e4ubel","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.ajog.2023.07.042_bib60","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1053\/j.semperi.2019.03.012","article-title":"Antenatal corticosteroids for low and middle income countries","volume":"43","author":"Jobe","year":"2019","journal-title":"Semin Perinatol"},{"key":"10.1016\/j.ajog.2023.07.042_bib61","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/08982104.2018.1556293","article-title":"Synthesis and in\u00a0vitro characterization of oxytocin receptor targeted PEGylated immunoliposomes for drug delivery to the uterus","volume":"29","author":"Hua","year":"2019","journal-title":"J\u00a0Liposome Res"},{"key":"10.1016\/j.ajog.2023.07.042_bib62","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2147\/IJN.S198116","article-title":"In\u00a0vitro comparison of liposomal drug delivery systems targeting the oxytocin receptor: a potential novel treatment for obstetric complications","volume":"14","author":"Hua","year":"2019","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.ajog.2023.07.042_bib63","doi-asserted-by":"crossref","first-page":"283.e1","DOI":"10.1016\/j.ajog.2016.08.027","article-title":"Drug delivery to the human and mouse uterus using immunoliposomes targeted to the oxytocin receptor","volume":"216","author":"Paul","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib64","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1124\/jpet.118.247668","article-title":"OBE022, an oral and selective prostaglandin F2alpha receptor antagonist as an effective and safe modality for the treatment of preterm labor","volume":"366","author":"Pohl","year":"2018","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.ajog.2023.07.042_bib65","unstructured":"ClinicalTrials.gov: U.S. National Library of Medicine."},{"key":"10.1016\/j.ajog.2023.07.042_bib66","doi-asserted-by":"crossref","first-page":"770","DOI":"10.3389\/fimmu.2020.00770","article-title":"A\u00a0broad spectrum chemokine inhibitor prevents preterm labor but not microbial invasion of the amniotic cavity or neonatal morbidity in a non-human primate model","volume":"11","author":"Coleman","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ajog.2023.07.042_bib67","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1021\/jm900133w","article-title":"Highly potent, orally available anti-inflammatory broad-spectrum chemokine inhibitors","volume":"52","author":"Fox","year":"2009","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.ajog.2023.07.042_bib68","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1111\/jcmm.12307","article-title":"Inhibition of infection-mediated preterm birth by administration of broad spectrum chemokine inhibitor in mice","volume":"18","author":"Shynlova","year":"2014","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.ajog.2023.07.042_bib69","doi-asserted-by":"crossref","first-page":"6132","DOI":"10.2174\/1381612823666170825145114","article-title":"Preterm birth and neonatal injuries: importance of interleukin-1 and potential of interleukin-1 receptor antagonists","volume":"23","author":"Nadeau-Vallee","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ajog.2023.07.042_bib70","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.98306","article-title":"IL-1 signaling mediates intrauterine inflammation and chorio-decidua neutrophil recruitment and activation","volume":"3","author":"Presicce","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.ajog.2023.07.042_bib72","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/ajmg.a.61124","article-title":"The burden of rare diseases","volume":"179","author":"Ferreira","year":"2019","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.ajog.2023.07.042_bib73","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1377\/hlthaff.2017.1179","article-title":"Evaluating the impact of the orphan drug act\u2019s seven-year market exclusivity period","volume":"37","author":"Sarpatwari","year":"2018","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.ajog.2023.07.042_bib76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1164\/rccm.201404-0703OC","article-title":"Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis","volume":"190","author":"Rowe","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl1","key":"10.1016\/j.ajog.2023.07.042_bib77","first-page":"S5","article-title":"Increasing life expectancy in cystic fibrosis: advances and challenges","volume":"57","author":"McBennett","year":"2022","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.ajog.2023.07.042_bib78","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/515S1a","article-title":"Sickle-cell disease","volume":"515","author":"Gravitz","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.ajog.2023.07.042_bib79","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.pcl.2018.01.005","article-title":"Treatment options for sickle cell disease","volume":"65","author":"Meier","year":"2018","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.ajog.2023.07.042_bib81","first-page":"987","article-title":"Cost-effectiveness and budget impact of Lumacaftor\/Ivacaftor in the treatment of cystic fibrosis","volume":"24","author":"Vadagam","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"},{"key":"10.1016\/j.ajog.2023.07.042_bib82","article-title":"Treating rare diseases in Africa: the drugs exist but the need is unmet","volume":"12","author":"Luzzatto","year":"2021","journal-title":"Front Pharmacol"},{"issue":"Suppl3","key":"10.1016\/j.ajog.2023.07.042_bib83","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2006.01120.x","article-title":"The preterm parturition syndrome","volume":"113","author":"Romero","year":"2006","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2023.07.042_bib84","doi-asserted-by":"crossref","first-page":"830.e1","DOI":"10.1016\/j.ajog.2015.08.028","article-title":"Uterine overdistention induces preterm labor mediated by inflammation: observations in pregnant women and nonhuman primates","volume":"213","author":"Adams Waldorf","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib85","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0002-9378(96)70221-1","article-title":"Inflammatory cytokine (interleukins 1, 6 and 8 and tumor necrosis factor-alpha) release from cultured human fetal membranes in response to endotoxic lipopolysaccharide mirrors amniotic fluid concentrations","volume":"174","author":"Fortunato","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib86","doi-asserted-by":"crossref","first-page":"306.e1","DOI":"10.1016\/j.ajog.2009.06.027","article-title":"Diversity in cytokine response to bacteria associated with preterm birth by fetal membranes","volume":"201","author":"Menon","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib87","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0002-9378(91)90422-N","article-title":"Neutrophil attractant\/activating peptide-1\/interleukin-8 in term and preterm parturition","volume":"165","author":"Romero","year":"1991","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib88","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0002-9378(98)70271-6","article-title":"A\u00a0fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition","volume":"179","author":"Romero","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib89","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0002-9378(94)70058-3","article-title":"The natural interleukin-1 receptor antagonist in the fetal, maternal, and amniotic fluid compartments: the effect of gestational age, fetal gender, and intrauterine infection","volume":"171","author":"Romero","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib90","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cytogfr.2015.11.001","article-title":"A\u00a0critical role of interleukin-1 in preterm labor","volume":"28","author":"Nadeau-Vall\u00e9e","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/j.ajog.2023.07.042_bib91","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1095\/biolreprod.109.080432","article-title":"The role of chemokines in term and premature rupture of the fetal membranes: a review","volume":"82","author":"Gomez-Lopez","year":"2010","journal-title":"Biol Reprod"},{"key":"10.1016\/j.ajog.2023.07.042_bib92","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3109\/14767058.2013.806898","article-title":"Fetal, amniotic and maternal inflammatory responses in early stage of ascending intrauterine infection, inflammation restricted to chorio-decidua, in preterm gestation","volume":"27","author":"Park","year":"2014","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.07.042_bib93","doi-asserted-by":"crossref","first-page":"142.e1","DOI":"10.1016\/j.ajog.2019.03.018","article-title":"Antibiotic administration can eradicate intra-amniotic infection or intra-amniotic inflammation in a subset of patients with preterm labor and intact membranes","volume":"221","author":"Yoon","year":"2019","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib94","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.3109\/14767058.2015.1103729","article-title":"A\u00a0new antibiotic regimen treats and prevents intra-amniotic inflammation\/infection in patients with preterm PROM","volume":"29","author":"Lee","year":"2016","journal-title":"J\u00a0Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2023.07.042_bib95","series-title":"Preterm birth: causes, consequences, and prevention","year":"2007"},{"key":"10.1016\/j.ajog.2023.07.042_bib96","doi-asserted-by":"crossref","first-page":"147.e1","DOI":"10.1016\/j.ajog.2006.09.014","article-title":"Trends in neonatal morbidity and mortality for very low birthweight infants","volume":"196","author":"Fanaroff","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.07.042_bib97","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clp.2013.09.007","article-title":"Pathogenesis and prevention of intraventricular hemorrhage","volume":"41","author":"Ballabh","year":"2014","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.ajog.2023.07.042_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1203\/PDR.0b013e3181c1b176","article-title":"Intraventricular hemorrhage in premature infants: mechanism of disease","volume":"67","author":"Ballabh","year":"2010","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajog.2023.07.042_bib99","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/PCC.0b013e3182917fad","article-title":"Trends in the epidemiology of pediatric severe sepsis\u2217","volume":"14","author":"Hartman","year":"2013","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.ajog.2023.07.042_bib100","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/nrgastro.2016.119","article-title":"Necrotizing enterocolitis: new insights into pathogenesis and mechanisms","volume":"13","author":"Ni\u00f1o","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823005148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823005148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:43:03Z","timestamp":1757590983000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823005148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":94,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0002937823005148"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.07.042","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Addressing a broken drug pipeline for preterm birth: why early preterm birth is an orphan disease","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.07.042","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}